Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05597267 · ClinicalTrials.gov registry record · NA

The MIRIA Acne Scar Study

A NA study of Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by AVAVA.

Active
Registry status
NA
Development phase
75
Enrollment target
3
Study locations

NCT05597267 is a NA study of Acne Scars - Mixed Atrophic and Hypertrophic that is active but no longer recruiting, run by AVAVA. The registered enrollment target is 75 participants, below the 101-participant average among 7 other Acne Scars - Mixed Atrophic and Hypertrophic trials with a reported enrollment target (26% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05597267, a NA study of Acne Scars - Mixed Atrophic and Hypertrophic, is active but no longer recruiting, sponsored by AVAVA.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
3
Study locations

Study Summary

This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.

Interventions

  • DEVICE MIRIA Laser

Study Locations (3)

Florida

  • Enchantress Dermatology - Miami

Massachusetts

  • AVAVA, Inc. - Waltham

New York

  • Laser and Skin Surgery Center of New York - New York

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-11-04
Est. Completion 2025-02-28
Phase NA

Sponsor

AVAVA

4 total trials

What the Registry Record Tells You About NCT05597267

The ClinicalTrials.gov registry entry for NCT05597267 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 7 other Acne Scars - Mixed Atrophic and Hypertrophic trials with a reported enrollment target (26% lower). The listed sponsor is AVAVA, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Scars - Mixed Atrophic and Hypertrophic appearing as the primary indexed condition, and to 1 intervention - of which MIRIA Laser is the first listed.

NCT05597267 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT05597267 about?

NCT05597267 is a clinical study titled "The MIRIA Acne Scar Study". This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 mon...

What is the current status of trial NCT05597267?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-11-04. Estimated completion is 2025-02-28.

What conditions does trial NCT05597267 study?

This clinical trial studies the following conditions: Acne Scars - Mixed Atrophic and Hypertrophic.

What interventions are being tested in trial NCT05597267?

The interventions under investigation include: MIRIA Laser (DEVICE).

Who is sponsoring clinical trial NCT05597267?

This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05597267 being conducted?

This trial has 3 study locations across Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne Scars - Mixed Atrophic and Hypertrophic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.